Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Karl D. Kieburtz"'
Autor:
Peter LeWitt, Grace S. Liang, C. Warren Olanow, Karl D. Kieburtz, Roland Jimenez, Kurt Olson, Olga Klepitskaya, Gordon Loewen
Publikováno v:
Clinical Neuropharmacology. 46:43-50
Autor:
Andrew McGarry, Peggy Auinger, Karl D. Kieburtz, Amy-Lee Bredlau, Steven M. Hersch, H. Diana Rosas
Publikováno v:
Neurol Clin Pract
Background and ObjectivesSuicidality is a common concern in the routine care of persons with Huntington disease (HD) and for the many participants in HD clinical trials. In a previous analysis, we identified baseline and time-dependent factors associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f165dc665255adfe4d95858e8c0d855f
https://europepmc.org/articles/PMC9208406/
https://europepmc.org/articles/PMC9208406/
Autor:
Andrew, Feigin, Elizabeth E, Evans, Terrence L, Fisher, John E, Leonard, Ernest S, Smith, Alisha, Reader, Vikas, Mishra, Richard, Manber, Kimberly A, Walters, Lisa, Kowarski, David, Oakes, Eric, Siemers, Karl D, Kieburtz, Maurice, Zauderer, Karen, Anderson
Publikováno v:
Nature medicine. 28(10)
SIGNAL is a multicenter, randomized, double-blind, placebo-controlled phase 2 study (no. NCT02481674) established to evaluate pepinemab, a semaphorin 4D (SEMA4D)-blocking antibody, for treatment of Huntington's disease (HD). The trial enrolled a tota
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 33(11)
Autor:
Peter A, LeWitt, Robert A, Hauser, Donald G, Grosset, Fabrizio, Stocchi, Marie-Helene, Saint-Hilaire, Aaron, Ellenbogen, Mika, Leinonen, Neil B, Hampson, Tia, DeFeo-Fraulini, Martin I, Freed, Karl D, Kieburtz
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 31(9)
Although levodopa is the most effective oral PD therapy, many patients experience motor fluctuations, including sudden loss of dose effect and delayed benefit. CVT-301 is a levodopa inhalation powder with the potential for rapid onset of action. The
Autor:
Michael, Wall, Mark J, Kupersmith, Karl D, Kieburtz, James J, Corbett, Steven E, Feldon, Deborah I, Friedman, David M, Katz, John L, Keltner, Eleanor B, Schron, Michael P, McDermott, David, Kaufman
Publikováno v:
JAMA neurology. 71(6)
Importance To our knowledge, there are no large prospective cohorts of untreated patients with idiopathic intracranial hypertension (IIH) to characterize the disease. Objective To report the baseline clinical and laboratory features of patients enrol
Autor:
Robert C. Griggs, Karl D. Kieburtz, Charles J. Duffy, Michael P. McDermott, Kathleen M. McGee
Publikováno v:
Neurology. 54:2197-2199
Autor:
LeWitt, Peter, Liang, Grace S., Olanow, C. Warren, Kieburtz, Karl D., Jimenez, Roland, Olson, Kurt, Klepitskaya, Olga, Loewen, Gordon
Publikováno v:
Clinical Neuropharmacology; Mar/Apr2023, Vol. 46 Issue 2, p43-50, 8p
Autor:
McGarry, Andrew, Auinger, Peggy MS, Kieburtz, Karl D., Bredlau, Amy-Lee, Hersch, Steven M., Rosas, H. Diana
Publikováno v:
Neurology: Clinical Practice; Apr2022, Vol. 12 Issue 2, p131-138, 8p
Autor:
Hampson, Neil B.1 (AUTHOR) neil.hampson@vmmc.org, Kieburtz, Karl D.2 (AUTHOR), LeWitt, Peter A.3 (AUTHOR), Leinonen, Mika4 (AUTHOR), Freed, Martin I.5 (AUTHOR)
Publikováno v:
International Journal of Neuroscience. Mar2017, Vol. 127 Issue 3, p276-284. 9p.